BASS XXV Tutorials and Keynote Address presentations:

SessionSpeakerPresentation
Keynote AddressDr. Karl E. Peace Joint Modeling of Time-to-and Laboratory Test Data Trial
M-1Joe Cappelleri Methods for Interpretation of Patient-Reported Outcomes
M-2Benjamin DuncanSafety Signal Detection: For Ongoing Clinical Trials, Utilizing a Bayesian Framework
M-3Ronald Wasserstein ASA’s Statement on P-values
M-5David KerrData Monitoring Committee Overview
M-6Matt DownsData Monitoring Committee
T-1Neal Thomas Design Stratification
T-2Keaven Anderson Non-proportional hazard models
T-3Abdullah Masud Evaluating treatment efficacy by combining multiple measures in clinical trial applications
T-4Ramses Sadek Oncology Adaptive Clinical Trials: Real Life Applications
T-5Vlad Dragalin Estimand
T-6Macaulay OkwuokenyeMultinational Real-world Studies in the Biopharmaceutical Industry: Design, Analysis, Issues, and Case studies
W-1Ling Chen
 Statistical Assessment of Abuse-deterrent Opioid Drug Products
W-2Hana LeeStudies to Evaluate the Risk of Abuse and Overdose for Prescription Opioids in the Real World
W-3Melvin MunsakaAdvanced Visual Analytics of Safety Data from Different Data Sources